Natco Pharma Limited has informed the Exchange regarding a press release dated January 30, 2025, titled "NATCO announces approval of its ANDA for Everolimus tablets".
Natco Pharma Limited has informed the Exchange regarding a press release dated January 30, 2025, titled "NATCO announces approval of its ANDA for Everolimus tablets".